Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: DrJerry who wrote (27730)	1/30/1999 6:49:00 PM
From: Lel H	Read Replies (3) \| Respond to of 32384

All right, I've got a legitimate question here. Please, I don't want to be crucified for speculating about LGND. We've known for a while that Ligand should be receiving official word from the FDA that Panretin and Ontak will be approved. When this announcement comes, it won't be a surprise to anyone who follows this stock. My question is thus: given the recent mini-run the LGND has made, is it possible that the value of the approval has already been priced into the stock? I'm sorry if this question has been addressed earlier, but this board is pretty difficult to follow. Thanks, Lel